Ozempic (semaglutide) does more than just control blood sugar. Research shows it can also lower blood pressure and reduce the chance of heart problems, even when blood sugar isn’t a factor.
Semaglutide activates the GLP-1 receptor. These receptors are also found in several parts of the body that affect blood pressure, such as the brain, blood vessels, kidneys, and the small organ in the neck that senses oxygen levels. These organs often function differently in people with high blood pressure. When GLP-1 receptor agonists activate these receptors, they can help these organs work better and lower blood pressure.
But can you take Ozempic along with your usual blood pressure medications? The sections below explain what current research shows and walk you through the home checks, lifestyle habits, and possible dose adjustments that can help you stay safe and get the best results.
Is it safe to take Ozempic with high blood pressure medications?

Yes, Ozempic can be used along with blood pressure medications like:
-
- ACE inhibitors
- ARBs
- diuretics (water pills)
- calcium channel blockers
- beta blockers
There’s no known direct interaction that makes these combinations unsafe, but your doctor will likely monitor you closely, especially during the first few months of treatment.
However, Ozempic can sometimes cause nausea, vomiting, or stomach discomfort, especially when you first start taking it or when your dose increases. These side effects can make it harder to stay hydrated. When you lose too much fluid, your kidneys have to work harder to filter your blood and maintain balance in your body.
This extra strain can temporarily affect how well your kidneys function. In some cases, if dehydration becomes severe, it may even lead to acute kidney injury, which is a sudden drop in kidney function. The FDA has received reports of this happening in people who became dehydrated while on Ozempic.
If that occurs, your doctor may pause blood pressure medications that put additional stress on your kidneys, such as diuretics, until your hydration improves. Once you’ve recovered and your kidney function returns to normal, your care team can gradually restart or adjust those medications to a safe level.
Can Ozempic lower blood pressure?
Yes, research consistently shows that Ozempic helps lower blood pressure, largely because of its weight loss effects. Researchers have long known that losing weight can lower blood pressure (BP).
In a meta-analysis, results showed that every kilogram of weight lost can lower blood pressure by about 1 mmHg.
A review looked at clinical trials involving people with high blood pressure who followed weight-loss diets. On average, participants’ weight decreased by about 4 kg (roughly 9 lbs), and their systolic blood pressure (SBP) also dropped by 4.5 mmHg.
This connection between weight reduction and lower BP helps explain why Ozempic, which leads to substantial weight loss, shows similar benefits.
In the SUSTAIN-6 trial, people taking semaglutide 0.5 mg saw their SBP drop by 3.4 mmHg after two years, while those on the 1.0 mg dose experienced an even greater reduction of 5.4 mmHg.
Another analysis found that semaglutide reduced SBP by about 4.8 mmHg and DBP (diastolic pressure) by 2.5 mmHg.
A larger review that included 20 clinical trials and more than 18,000 people taking semaglutide found similar results. On average, SBP decreased by 3.7 mmHg and DBP by 1.1 mmHg. The reduction was most pronounced among individuals who:
-
- Did not have diabetes
- Had lower baseline HbA1c levels
- Had a BMI over 35 (severe obesity)
- Used higher doses of semaglutide (over 1 mg weekly)
- Began with systolic BP less than or equal to 130 mmHg
- Lost more than 10 kg or reduced their BMI by more than 3 units
- Continued treatment for 50-100 weeks
The researchers also found that the amount of weight lost was directly linked to how much blood pressure dropped.
A separate individual patient data analysis of three major trials (totaling 3,136 participants) compared semaglutide with placebo. On average, SBP fell by about 5 mmHg more in those taking semaglutide. The reductions were similar across different hypertension categories:
-
- People diagnosed or treated for hypertension: 4.8 mmHg
- Those with SBP above 130 mmHg: 4.9 mmHg
- Those with SBP above 140 mmHg: 4.1 mmHg
- Those with resistant hypertension: 3.2 mmHg
Consistent with earlier findings, much of the blood pressure drop appeared to be due to weight loss from semaglutide. Participants on semaglutide also required fewer or lower doses of antihypertensive medication, indicating better overall blood pressure control.
Can Ozempic alone help with high blood pressure?
Guidelines recommend keeping your blood pressure below 130/80 mmHg, as long as it’s safe for you. Ozempic can help you move closer to that goal, but it’s not meant to replace your regular blood pressure treatments. You’ll still need to take your prescribed medications and follow healthy habits, such as:
-
- checking your blood pressure at home
- cutting back on salt
- staying active
- getting enough sleep
In many cases, you may also need one or more blood pressure medications to stay within your target range. Your healthcare provider will follow ADA and cardiology guidelines to help choose and adjust the right medicines for you.
Patient Experiences with Ozempic and High Blood Pressure
On a Reddit post, someone shared their experience of developing severely high blood pressure after starting Wegovy and later switching to Ozempic samples due to insurance issues. The individual had been on blood pressure medication for 15 years without issues, but began experiencing dangerous spikes a few weeks after beginning semaglutide.
Their blood pressure normalized after stopping Ozempic, but they needed time and medication adjustments to recover.
Several users joined the discussion. Some users described blood pressure readings as high as 180/115 to 230/143 mmHg, sometimes requiring emergency care or additional antihypertensive medications. A few said their heart rate also increased while on Ozempic.
But not everyone had negative outcomes. Several users said their blood pressure actually improved on Ozempic, particularly as they lost weight. Some even reported reducing or discontinuing BP medications after a few months.
One participant said her cardiologist confirmed seeing multiple patients with the same pattern, blood pressure spiking on injection days, sometimes reaching 210/127 mmHg, then normalizing afterward. Her doctor managed it by using valsartan and hydralazine when spikes occurred.
Another post was written by someone who wanted to caution others taking Ozempic while on blood pressure medication. The poster shared that they had fainted outdoors on a hot day after eating very little and mostly drinking water.
When emergency services arrived, their blood pressure was dangerously low (82/56), and hospital tests showed electrolyte imbalances, low potassium, and impaired kidney function. They were hospitalized for three days and later stopped taking blood pressure medication entirely.
Some described experiencing low blood pressure and dizziness while losing weight on Ozempic, which led their doctors to reduce or stop blood pressure medications. Others reported fainting or feeling lightheaded from dehydration or poor electrolyte intake.
A few noted that semaglutide slows digestion, which can alter how the body absorbs medications, including thyroid and blood pressure drugs, potentially requiring dose adjustments. Several others shared that their blood pressure improved as they lost weight on Ozempic, sometimes allowing them to come off antihypertensive drugs entirely.
The bottom line
Ozempic is generally safe to take with blood pressure medications since there are no known direct drug interactions. But dehydration from nausea or vomiting can temporarily affect kidney function, so close monitoring is important.
Studies show that Ozempic can lower blood pressure by 3-5 mmHg on average, mainly due to weight loss. The more weight you lose, the greater the improvement in blood pressure. Some people are even able to reduce or stop their blood pressure medications after consistent use.
However, Ozempic should not replace your prescribed blood pressure treatments. Continue taking your medications, stay hydrated, limit salt, and check your blood pressure regularly. If you notice dizziness, fainting, or changes in your readings, contact your doctor right away for dose adjustments.
Related Articles
Frequently Asked Questions
Sources
Ribeiro-Silva, J. C., Tavares, C. A., & Girardi, A. C. (2023). The blood pressure lowering effects of glucagon-like peptide-1 receptor agonists: A mini-review of the potential mechanisms. Current Opinion in Pharmacology, 69, 102355. https://doi.org/10.1016/j.coph.2023.102355
Neter, J. E., Stam, B. E., Kok, F. J., Grobbee, D. E., & Geleijnse, J. M. (2003). Influence of weight reduction on blood pressure. Hypertension, 42(5), 878–884. https://doi.org/10.1161/01.hyp.0000094221.86888.ae
Semlitsch, T., Krenn, C., Jeitler, K., Berghold, A., Horvath, K., & Siebenhofer, A. (2021). Long-term effects of weight-reducing diets in people with hypertension. Cochrane Library, 2021(2). https://doi.org/10.1002/14651858.cd008274.pub4
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., Woo, V., Hansen, O., Holst, A. G., Pettersson, J., & Vilsbøll, T. (2016). Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. New England Journal of Medicine, 375(19), 1834–1844. https://doi.org/10.1056/nejmoa1607141
Kennedy, C., Hayes, P., Salama, S., Hennessy, M., & Fogacci, F. (2023). The Effect of Semaglutide on Blood Pressure in Patients without Diabetes: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 12(3), 772. https://doi.org/10.3390/jcm12030772
Ala, M., & Aleaba, M. M. (2024). The blood pressure-lowering property of subcutaneous semaglutide: a systematic review, meta-analysis, and meta-regression. Journal of Endocrinological Investigation. https://doi.org/10.1007/s40618-024-02459-3
Kennedy, C., Hayes, P., Cicero, A. F. G., Dobner, S., Roux, C. W. L., McEvoy, J. W., Zgaga, L., & Hennessy, M. (2024). Semaglutide and blood pressure: an individual patient data meta-analysis. European Heart Journal. https://doi.org/10.1093/eurheartj/ehae564
ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Early, K. B., Bruemmer, D., Das, S. R., Echouffo-Tcheugui, J. B., Ekhlaspour, L., Garg, R., Khunti, K., Kosiborod, M. N., Lal, R., Lingvay, I., Matfin, G., Pandya, N., Pekas, E. J., Pilla, S. J., . . . Bannuru, R. R. (2024). 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025. Diabetes Care, 48(Supplement_1), S207–S238. https://doi.org/10.2337/dc25-s010




